184 related articles for article (PubMed ID: 23565285)
1. Gain-of-function of Stat5 leads to excessive granulopoiesis and lethal extravasation of granulocytes to the lung.
Lin WC; Schmidt JW; Creamer BA; Triplett AA; Wagner KU
PLoS One; 2013; 8(4):e60902. PubMed ID: 23565285
[TBL] [Abstract][Full Text] [Related]
2. STAT5 requires the N-domain to maintain hematopoietic stem cell repopulating function and appropriate lymphoid-myeloid lineage output.
Li G; Wang Z; Zhang Y; Kang Z; Haviernikova E; Cui Y; Hennighausen L; Moriggl R; Wang D; Tse W; Bunting KD
Exp Hematol; 2007 Nov; 35(11):1684-94. PubMed ID: 17976521
[TBL] [Abstract][Full Text] [Related]
3. Leukemogenic Ptpn11 causes fatal myeloproliferative disorder via cell-autonomous effects on multiple stages of hematopoiesis.
Chan G; Kalaitzidis D; Usenko T; Kutok JL; Yang W; Mohi MG; Neel BG
Blood; 2009 Apr; 113(18):4414-24. PubMed ID: 19179468
[TBL] [Abstract][Full Text] [Related]
4. Stat5a serine 725 and 779 phosphorylation is a prerequisite for hematopoietic transformation.
Friedbichler K; Kerenyi MA; Kovacic B; Li G; Hoelbl A; Yahiaoui S; Sexl V; Müllner EW; Fajmann S; Cerny-Reiterer S; Valent P; Beug H; Gouilleux F; Bunting KD; Moriggl R
Blood; 2010 Sep; 116(9):1548-58. PubMed ID: 20508164
[TBL] [Abstract][Full Text] [Related]
5. Gab2 promotes hematopoietic stem cell maintenance and self-renewal synergistically with STAT5.
Li G; Wang Z; Miskimen KL; Zhang Y; Tse W; Bunting KD
PLoS One; 2010 Feb; 5(2):e9152. PubMed ID: 20161778
[TBL] [Abstract][Full Text] [Related]
6. Bortezomib inhibits STAT5-dependent degradation of LEF-1, inducing granulocytic differentiation in congenital neutropenia CD34(+) cells.
Gupta K; Kuznetsova I; Klimenkova O; Klimiankou M; Meyer J; Moore MA; Zeidler C; Welte K; Skokowa J
Blood; 2014 Apr; 123(16):2550-61. PubMed ID: 24394665
[TBL] [Abstract][Full Text] [Related]
7. Stat5 deficiency decreases transcriptional heterogeneity and supports emergence of hematopoietic sub-populations.
Wang Z; Bunting KD
Oncotarget; 2017 Apr; 8(14):22477-22482. PubMed ID: 28390194
[TBL] [Abstract][Full Text] [Related]
8. Stat5-deficient hematopoiesis is permissive for Myc-induced B-cell leukemogenesis.
Wang Z; Medrzycki M; Bunting ST; Bunting KD
Oncotarget; 2015 Oct; 6(30):28961-72. PubMed ID: 26338970
[TBL] [Abstract][Full Text] [Related]
9. Lineage-specific STAT5 target gene activation in hematopoietic progenitor cells predicts the FLT3(+)-mediated leukemic phenotype.
Müller TA; Grundler R; Istvanffy R; Rudelius M; Hennighausen L; Illert AL; Duyster J
Leukemia; 2016 Aug; 30(8):1725-33. PubMed ID: 27046463
[TBL] [Abstract][Full Text] [Related]
10. Conditional deletion of STAT5 in adult mouse hematopoietic stem cells causes loss of quiescence and permits efficient nonablative stem cell replacement.
Wang Z; Li G; Tse W; Bunting KD
Blood; 2009 May; 113(20):4856-65. PubMed ID: 19258595
[TBL] [Abstract][Full Text] [Related]
11. Enforced activation of STAT5A facilitates the generation of embryonic stem-derived hematopoietic stem cells that contribute to hematopoiesis in vivo.
Schuringa JJ; Wu K; Morrone G; Moore MA
Stem Cells; 2004; 22(7):1191-204. PubMed ID: 15579639
[TBL] [Abstract][Full Text] [Related]
12. IL-3-induced enhancement of retinoic acid receptor activity is mediated through Stat5, which physically associates with retinoic acid receptors in an IL-3-dependent manner.
Si J; Collins SJ
Blood; 2002 Dec; 100(13):4401-9. PubMed ID: 12393611
[TBL] [Abstract][Full Text] [Related]
13. O-GlcNAcylation of STAT5 controls tyrosine phosphorylation and oncogenic transcription in STAT5-dependent malignancies.
Freund P; Kerenyi MA; Hager M; Wagner T; Wingelhofer B; Pham HTT; Elabd M; Han X; Valent P; Gouilleux F; Sexl V; Krämer OH; Groner B; Moriggl R
Leukemia; 2017 Oct; 31(10):2132-2142. PubMed ID: 28074064
[TBL] [Abstract][Full Text] [Related]
14. The transcription factors STAT5A/B regulate GM-CSF-mediated granulopoiesis.
Kimura A; Rieger MA; Simone JM; Chen W; Wickre MC; Zhu BM; Hoppe PS; O'Shea JJ; Schroeder T; Hennighausen L
Blood; 2009 Nov; 114(21):4721-8. PubMed ID: 19779039
[TBL] [Abstract][Full Text] [Related]
15. STAT5 signaling in normal and pathologic hematopoiesis.
Bunting KD
Front Biosci; 2007 May; 12():2807-20. PubMed ID: 17485261
[TBL] [Abstract][Full Text] [Related]
16. STAT5 signaling is required for the efficient induction and maintenance of CML in mice.
Ye D; Wolff N; Li L; Zhang S; Ilaria RL
Blood; 2006 Jun; 107(12):4917-25. PubMed ID: 16522816
[TBL] [Abstract][Full Text] [Related]
17. Antiapoptotic activity of Stat5 required during terminal stages of myeloid differentiation.
Kieslinger M; Woldman I; Moriggl R; Hofmann J; Marine JC; Ihle JN; Beug H; Decker T
Genes Dev; 2000 Jan; 14(2):232-44. PubMed ID: 10652277
[TBL] [Abstract][Full Text] [Related]
18. STAT5 requires the N-domain for suppression of miR15/16, induction of bcl-2, and survival signaling in myeloproliferative disease.
Li G; Miskimen KL; Wang Z; Xie XY; Brenzovich J; Ryan JJ; Tse W; Moriggl R; Bunting KD
Blood; 2010 Feb; 115(7):1416-24. PubMed ID: 20008792
[TBL] [Abstract][Full Text] [Related]
19. A STAT5 modifier locus on murine chromosome 7 modulates engraftment of hematopoietic stem cells during steady-state hematopoiesis.
Couldrey C; Bradley HL; Bunting KD
Blood; 2005 Feb; 105(4):1476-83. PubMed ID: 15498858
[TBL] [Abstract][Full Text] [Related]
20. Hematopoietic-repopulating defects from STAT5-deficient bone marrow are not fully accounted for by loss of thrombopoietin responsiveness.
Bradley HL; Couldrey C; Bunting KD
Blood; 2004 Apr; 103(8):2965-72. PubMed ID: 15070672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
